Evidence-based Recommendations for the Use of WBC-reduced Cellular Blood Components

Transfusion. 2001 Oct;41(10):1310-9. doi: 10.1046/j.1537-2995.2001.41101310.x.

Publication types

  • Consensus Development Conference
  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Blood Component Transfusion / adverse effects
  • Blood Component Transfusion / methods
  • Blood Component Transfusion / standards*
  • Blood Preservation
  • Cost-Benefit Analysis
  • Evidence-Based Medicine*
  • Humans
  • Leukapheresis* / economics
  • Leukapheresis* / methods
  • Leukapheresis* / standards
  • Risk Assessment
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence
  • Universal Precautions